Breakthrough venous thromboembolic events in five patients with COVID‐19 on direct oral anticoagulants
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Pharmacy and Therapeutics"
DOI: 10.1111/jcpt.13311
Abstract: Coronavirus disease 2019 (COVID‐19) is associated with increased risk of venous thromboembolism (VTE). Guidance for VTE prophylaxis continues to evolve, including addressing direct oral anticoagulants (DOACs) continued upon hospitalization. read more here.
Keywords: thromboembolic events; events five; oral anticoagulants; direct oral ... See more keywords